Research Reports

Key takeaways

Drs. Frances Arnold, Robert S. Epstein, and Gary S. Guthart to retire as directors effective May 21, 2026.

Retirements not due to any dispute or disagreement with the Company or Board.

Board nominates David P. King for election at 2026 annual meeting of stockholders.

David P. King is former Executive Chairman and CEO of Laboratory Corporation of America Holdings.

King currently serves as director and chair of Privia Health and AmSurg Corporation, and director of Smith & Nephew.

Full analysis

Illumina's Board changes involve the planned retirement of three experienced directors—Drs. Frances Arnold, Robert S. Epstein, and Gary S. Guthart—effective at the 2026 annual meeting on May 21, 2026, explicitly stated as not resulting from any disagreements. This refreshment nominates David P. King, bringing deep healthcare and life sciences expertise from his prior roles as Executive Chairman and CEO of LabCorp, and current board positions at Privia Health, AmSurg, and Smith & Nephew. Chair Scott Gottlieb highlighted King's operating experience and regulatory insight to advance Illumina's genomics integration into medicine, signaling continuity and strategic evolution for investors.

ILMN · Illumina, Inc.

Summary

Key takeaways

Full analysis